10.31.24 -- Life Sciences Cybersecurity Incident Management: The End-to-End Approach

Particle counting efficiency is vital, especially when using optical particle counters. Learn why 50% is the limit for counting efficiency sizing thresholds in optical particle counters.

Residues from cleaning agents can pose significant risks to cleanroom operations. Learn about residue management, measurement techniques, and best practices to ensure compliance and product safety.

Although most legislation concerning the traceability of pharma products focuses on serialization rather than aggregation, the latter is an essential component of internal and external traceability of products.

Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.

Containment is growing in importance due to increasingly stringent legal requirements for packaging solid medicines. Learn in detail about containment solutions for the pharmaceutical industry.

Explore how, in combination with artificial intelligence, augmented reality, robotics, and digital twins, biopharma 4.0 is changing legacy concepts from the ground up.

Conventional delivery methods for RNA therapeutics face limitations. Implant devices deliver a higher concentration of the therapeutic and offer sustained release for improved efficacy.

GMP compliance requires monitoring microbial contamination levels in cleanrooms and clean spaces. It is important to know the role active air samplers play in this process and parameters for evaluating them.

Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets and project timelines, and identify potential supply-related issues before they negatively impact a study.

Discover three key steps you can follow to streamline the selection process and identify the CMOs best suited to help your organization achieve its goals, quickly bring products to market, and more.

Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.

Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.